Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

Find My GLP-1 Path
Last verified: The RX Index Editorial TeamDisclosure

UnitedHealthcare Mounjaro Prior Authorization: What UHC Requires in 2026

The exact A1C cutoffs, the metformin rule UHC dropped, a denial decoder, and who files the appeal — based on your actual situation.

Disclosure: The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We may earn a commission when you start care through some provider links. It costs you nothing extra, and it never changes a plan’s rules or our recommendations. Some links are sponsored and flagged plainly — they never change what we report. This guide is information, not medical or insurance advice.
Bottom line: UnitedHealthcare Mounjaro prior authorization almost always comes down to one question: can your records prove you have type 2 diabetes? Under UHC’s current commercial rules, that mainly means one qualifying lab — usually an A1C of 6.5% or higher, or a fasting blood sugar of 126 mg/dL or higher. UHC will not cover Mounjaro for weight loss. Approval lasts 12 months.

Your fastest UHC Mounjaro answer

Your situationThe likely pathDo this next
Type 2 diabetes, documentedMounjaro PA has a real pathUse the checklist below; have your prescriber submit the labs and notes
Type 2 diabetes, but A1C is normal nowContinuation proof mattersSend older diagnosis labs + notes showing ongoing diabetes care
Want Mounjaro for weight loss, no diabetesUsually the wrong drug to requestCheck whether your plan covers Zepbound (FDA-approved weight-loss tirzepatide)
Denied for "missing records"Often fixableResubmit with the exact records UHC asked for
Denied because your plan excludes the useHardest to reverseLook at the savings card, a different covered use, or cash-pay

What we actually verified for this guide

Every fact below was checked against a primary source on . Sources are linked at the bottom.

What we checkedWhat we foundSource
Is Mounjaro on UHC's list?On UHC's 2026 commercial PDL (eff. May 1, 2026), requires prior authorization, with a quantity limit. Typically Tier 2. UHC states the list "does not define benefit coverage" -- your plan does.UHC 2026 commercial PDL
What does the PA require?Medical records confirming type 2 diabetes by A1C ≥6.5%, fasting glucose ≥126 mg/dL, 2-hr glucose ≥200 mg/dL, or random glucose ≥200 mg/dL with symptoms -- or chart notes if diagnosed more than 2 years ago. Approval runs 12 months.UHC commercial GLP-1 PA policy (eff. 7/1/2025)
Is metformin step therapy required?UnitedHealthcare removed step-therapy language from its standard commercial GLP-1 policy in April 2024. Some employer plans may still add their own.UHC GLP-1 PA policy change log
Mounjaro for weight loss?UHC's policy says these GLP-1s are not FDA-approved for weight loss, and weight-loss drugs are typically excluded unless your plan adds the benefit.UHC commercial GLP-1 PA policy
Cost if you can't get it coveredLilly's Mounjaro Savings Card: as little as $25 for eligible patients with commercial insurance that covers Mounjaro; as low as $499 for a 1-month fill with commercial insurance that doesn't cover it. Government plans not eligible. Card expires 12/31/2026.Lilly official savings terms
SafetyMounjaro carries an FDA boxed warning for thyroid C-cell tumors. Not for people with a personal or family history of MTC or MEN 2.FDA prescribing information (DailyMed), revised April 2026

Does UnitedHealthcare cover Mounjaro?

UnitedHealthcare may cover Mounjaro when your plan includes it and you meet the prior authorization rules. Mounjaro is on UHC’s 2026 commercial drug list with prior authorization and a quantity limit, but UHC is clear the list alone doesn’t decide your coverage — your plan’s benefit design does. That’s why two people who both “have UnitedHealthcare” can get two different answers.

A few words that trip people up

TermPlain English
Formulary / PDLThe menu of drugs your plan covers
TierThe price group a drug sits in. Lower tier, lower copay. Mounjaro is usually Tier 2 (mid-range).
Prior authorization (PA)The permission step -- your doctor proves you qualify before UHC pays
Quantity limit (QL)A cap on how much you can get per fill
OptumRxThe pharmacy benefit manager UHC uses to run its drug coverage

UHC formulary snapshot — 2026 commercial PDL

DrugEffectiveTierFlagsWhat it means
Mounjaro (tirzepatide)May 1, 20262 (mid-range)PA, QLPrior authorization and a quantity limit apply; your plan controls your actual cost and coverage

A pharmacy rejection isn’t the final answer

If the pharmacy says “needs prior authorization,” that’s the start of a process, not a no. Here’s the flow:

  1. Pharmacy flags “PA required.”
  2. Your prescriber submits the PA to UHC’s pharmacy benefit manager — OptumRx.
  3. UHC/OptumRx checks your case against the rules.
  4. You get approved, denied, or a request for more info.

Often, what feels like a flat “no” is really this step — the plan asking for a missing lab or note.

Commercial vs. Medicare vs. Medicaid

Plan typeMounjaro coverage
Commercial / employerFollows the criteria below; some employers add extra rules. This guide covers this type.
UHC Medicare Advantage (Part D)Can cover Mounjaro for diabetes with PA -- not for weight loss. See Medicare section below.
UHC Community Plan (Medicaid)Varies by state. Confirm with your state's preferred drug list.

What are UnitedHealthcare’s Mounjaro prior authorization requirements?

Quick answer: UHC’s commercial policy wants medical records confirming type 2 diabetes. You can prove it with one qualifying lab — or, if you were diagnosed more than two years ago, with chart notes showing ongoing diabetes care. When approved, the authorization lasts 12 months.
Source: UnitedHealthcare commercial GLP-1 PA policy, effective July 1, 2025.

Here are the exact lab values UHC lists. Your doctor needs one of them:

What proves type 2 diabetes (any one)What to collect
A1C ≥ 6.5% (average blood sugar over ~3 months)Lab report with date and value
Fasting plasma glucose ≥ 126 mg/dLLab report noting you fasted (8-hour fast)
2-hour glucose ≥ 200 mg/dL on a glucose tolerance testTest report
Random glucose ≥ 200 mg/dL plus classic symptoms or a sugar crisisLab report + a note describing the symptoms
Diagnosed more than 2 years ago, still in treatmentChart notes confirming the diagnosis and ongoing care

Does UnitedHealthcare make you fail metformin first?

No — not on the standard commercial policy. UnitedHealthcare removed step-therapy language from its commercial GLP-1 policy in April 2024. The standard policy doesn’t require failing metformin first.
The honest caveat: A specific employer or self-funded plan can still add its own step therapy. Confirm your plan. If you get a step-therapy denial, it’s coming from your plan’s add-on, not the base policy — and that changes how you respond (see the denial section below).

Why this matters: If your doctor’s office assumes step therapy and pads the request with “failed metformin” notes you don’t have, it can slow you down for no reason.

What if my A1C is normal now because the medicine is working?

Your treatment is working — your A1C dropped below 6.5%. But now a renewal looks like you “don’t qualify.” You still have diabetes; the number just looks good because treatment is doing its job.

The fix: ask your clinician to include your original diagnosis labs, older chart notes, and your treatment history. UHC’s policy has a built-in path for people diagnosed more than two years ago that relies on documented history, not a fresh high A1C.

Will UnitedHealthcare approve Mounjaro for weight loss?

No — UnitedHealthcare treats Mounjaro as a type 2 diabetes drug. Its policy says these GLP-1s aren’t FDA-approved for weight loss, and weight-loss drugs are typically excluded unless your plan adds that benefit. If weight loss is your real goal and you don’t have diabetes, the better-matched FDA-approved option is Zepbound.

Mounjaro and Zepbound share the same active ingredient (tirzepatide) — but they’re different brands with different FDA approvals, and insurance treats them in different lanes. That difference is your whole strategy:

MedicationFDA-approved forUHC policy laneBest fit
Mounjaro (tirzepatide)Type 2 diabetesDiabetes GLP-1 PADocumented type 2 diabetes
Zepbound (tirzepatide)Weight loss; obstructive sleep apneaSeparate weight-loss PA (if plan adds it)Weight loss (BMI 30+, or 27+ with a related condition)
Wegovy (semaglutide)Weight loss; certain heart-risk/liver usesSeparate weight-loss PA (if plan adds it)Weight loss, depending on your plan
When to stop chasing Mounjaro: if the denial says “no type 2 diabetes” or “non-covered weight-loss use,” do not ask anyone to code diabetes you don’t have. That’s fraud. Pivot to the right covered use, or a cash-pay route.

Weight-loss goal? Check your GLP-1 coverage first.

Ro’s free GLP-1 Insurance Coverage Checker contacts your insurer and sends a plain-English report of what’s covered and whether a PA is required. It does not submit a prescription or a prior authorization. Ro does not offer Mounjaro — it offers Zepbound in its Body Program. If you specifically need Mounjaro for diabetes, your own prescriber is the right route.

Check my GLP-1 coverage with Ro → free (sponsored affiliate link, opens in a new tab)

Sponsored. For Zepbound/Wegovy weight-loss path. Ro does not offer Mounjaro.


What documents should your doctor submit for a Mounjaro PA?

The strongest UHC Mounjaro PA isn’t a prescription — it’s a diagnosis-and-evidence packet. Get this right the first time and you skip the back-and-forth that drags requests out for weeks. Copy the checklist below and bring it to your doctor’s office.

Your plan and pharmacy details

  • UHC member ID
  • RxBIN, RxPCN, RxGroup, and group number (on your card)
  • Your pharmacy's name
  • Prescriber name, NPI, phone, and fax
  • The authorization number, if one already exists

Your diagnosis proof

  • Type 2 diabetes diagnosis code (your clinician's call -- only if accurate)
  • A lab report: A1C, fasting glucose, glucose tolerance test, or random glucose
  • Chart notes confirming the diagnosis
  • The date you were diagnosed

Your treatment history

  • Current and past diabetes medications
  • Your Mounjaro dose and titration plan
  • Any prior GLP-1 use
  • A prior approval letter, if you've been on it before
  • A reason for continuing, if you already take it

If you’re fixing a denial, match the records to the reason

If the denial says…Attach this
"No chart notes submitted"A recent office note plus a diagnosis lab
"Diagnosis not confirmed"A lab or older note confirming type 2 diabetes
"Use not covered"Check whether the request went in for diabetes vs. weight loss
"Quantity limit exceeded"A note clarifying dose, day supply, and fill quantity
"Prior authorization not received"The submission date, portal confirmation, and authorization number

How do you submit a UHC or OptumRx Mounjaro prior authorization?

Your prescriber submits the PA — not you. But you can do the three things that actually move it: confirm it was submitted, find out what’s missing, and get the exact denial reason in writing.

Providers can request PA through PreCheck MyScript (a tool in UHC’s provider system), online through OptumRx, or by phone with the OptumRx prior authorization team.

How long does it take? Many plans decide a standard pharmacy PA within a few business days to about two weeks, and urgent requests faster — often within about 72 hours. Ask UnitedHealthcare or OptumRx for the exact deadline on your request and whether you qualify for an expedited review.

Scripts to move it along

Call the pharmacy:

Can you tell me exactly what the rejection says -- prior authorization required, not covered, quantity limit, or plan exclusion?

Call your doctor's office:

Was the Mounjaro prior authorization submitted through OptumRx or UHC's portal, on what date, and do you have an authorization or reference number?

Call UnitedHealthcare (number on your card):

What's the exact reason my Mounjaro prior authorization is pending or denied, and has a denial letter been sent?

Write down names, dates, and reference numbers every time. That paper trail is what your prescriber — or your appeal — uses to fix the exact problem.

What if UnitedHealthcare denies Mounjaro?

A denial isn’t one problem — it’s several, and each has a different fix. Read the exact reason first, because it decides whether you simply resubmit, file an appeal, or change your strategy.

The UHC Mounjaro denial decoder

What the denial saysWhat it usually meansYour best next step
Missing chart notesUHC didn't get enough recordsResubmit with chart notes + a diagnosis lab
No confirmed type 2 diabetesThe request didn't prove diabetesAdd diagnosis labs/notes if accurate -- otherwise pivot
Weight loss / off-label useThe request doesn't fit the diabetes policyAsk about the Zepbound/Wegovy weight-loss path if your plan covers it
Plan exclusionYour benefit design doesn't cover this useAppeals are weak here -- check HR/benefits, a different use, or the savings card
Quantity limitDose or day supply tops the capAlign quantity and day supply, or request an exception
PA not receivedA paperwork or routing failureConfirm the submission channel, date, and reference number
Reauthorization deniedContinuation proof was missingSend original diagnosis proof + treatment history + current notes

Resubmit, appeal, or stop — how to tell

Resubmit when the issue is missing records or a routing failure. It’s often faster than a formal appeal.
Appeal when UHC misread evidence that’s already in your chart, or records didn’t reach them.
Stop and pivot when there’s no diabetes and your plan excludes weight-loss drugs. A diabetes-based Mounjaro appeal can’t fix a benefit exclusion.

How do you appeal a UnitedHealthcare Mounjaro denial?

Yes, you can appeal — but the appeal has to answer the exact reason on your denial letter. UnitedHealthcare allows an appeal from the member, a representative, or the prescriber. In practice, your prescriber usually supplies the clinical proof.

The appeal workflow

  1. Get the denial letter in hand.
  2. Identify the exact denial reason.
  3. Ask UHC which policy or criteria they used.
  4. Ask your prescriber whether your chart supports the diabetes diagnosis.
  5. Attach the matching labs and chart notes.
  6. Ask whether a peer-to-peer review (your doctor talks directly with the plan's reviewer) is available.
  7. File through the route on the denial letter, before the deadline.
  8. Track the confirmation number and the timeline.
What a strong case usually includes: the diagnosis, objective labs, your current treatment, your history, why Mounjaro is appropriate for you, and a direct answer to the denial reason. Talk it through with your prescriber — don’t write a fake letter.
What not to do: don’t ask a clinician to record diabetes you don’t have, and don’t send a generic appeal that never addresses why you were denied.

How much does Mounjaro cost if UnitedHealthcare doesn’t approve it?

If UHC won’t cover it, your cheapest legitimate path is usually Eli Lilly’s Mounjaro Savings Card — if you qualify. The prescription must be for an FDA-approved use (diabetes). Source: Lilly’s official savings terms.

Your situationPossible pathThe catch
Commercial insurance covers MounjaroSavings card -> as little as $25 per fillUp to 13 fills/year; annual cap of $1,950; card expires 12/31/2026
Commercial insurance doesn't cover MounjaroSavings card -> as low as $499 for a one-month fillFDA-approved use only; annual cap of $8,411; card expires 12/31/2026
Medicare, Medicaid, VA, TRICARE, or other government planSavings card not availableCheck your plan's formulary and appeal rules instead
No qualifying commercial coverageSavings card may not applyExpect close to full price -- often more than $1,000/month
The card is not insurance, has monthly and annual caps, and expires 12/31/2026 (Lilly can change it sooner). That “$25” only works for an FDA-approved use (diabetes) — it’s not a backdoor to weight-loss coverage.

See full breakdown: Mounjaro cost without insurance →


Mounjaro, Zepbound, or Wegovy with UnitedHealthcare — which should you ask for?

Matching the drug to your real diagnosis is what turns a long fight into a short one. A quick decision tree:

  • Documented type 2 diabetes? -> Mounjaro (or another diabetes GLP-1) is your lane.
  • No diabetes, BMI 30+? -> Check weight-loss coverage for Zepbound or Wegovy.
  • BMI 27+ with a related condition (like high blood pressure or sleep apnea)? -> Check the weight-loss criteria and whether your plan opted in.
  • Obesity plus moderate-to-severe sleep apnea? -> Ask about the Zepbound sleep-apnea route.
  • Plan excludes weight-loss drugs? -> Look at savings cards, cash-pay programs, or a different covered use.

Does UnitedHealthcare cover Mounjaro under Medicare or Medicaid?

A UHC Medicare Advantage plan with Part D can cover Mounjaro for type 2 diabetes with prior authorization, but Medicare doesn’t cover GLP-1s prescribed purely for weight loss. UHC Community Plan (Medicaid) coverage varies by state and also centers on a diabetes diagnosis.

Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027): Eligible Medicare Part D members pay a $50 copay outside the normal Part D flow. CMS lists eligible drugs as Foundayo, Wegovy (injection and tablets), and Zepbound (KwikPen)not Mounjaro, because Mounjaro is a diabetes drug, not a weight-loss drug. Even as Medicare opens up for weight loss, Mounjaro stays in the diabetes lane.

Confirm your specific plan, because government-plan rules differ from the commercial criteria above. For Medicaid, check your state’s preferred drug list and your denial letter before assuming the commercial rules apply.


What safety information matters before you fight for coverage?

This guide helps with the insurance side. It can’t tell you whether Mounjaro is right for you — only a licensed clinician can.

The boxed warning (FDA’s most serious warning): Mounjaro carries an FDA boxed warning for thyroid C-cell tumors seen in rats. It should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or a condition called MEN 2 (Multiple Endocrine Neoplasia syndrome type 2).
Source: FDA prescribing information on DailyMed, revised April 2026.
A few things to keep straight:
  • Coverage approval is not the same as being medically appropriate. Those are two different yeses.
  • Known serious risks include pancreatitis, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, gallbladder issues, vision changes, and a risk of food entering the lungs during anesthesia.
  • Don’t use this page to self-diagnose or to push a prescriber. Bring it as a coverage roadmap, not a diagnosis.

Why we built this as a checklist, not another “maybe covered” article

Most pages answer “does UHC cover Mounjaro?” and stop. But that’s not the question keeping you up. You want to know why the PA failed, what your doctor should send, and what to do before the next refill. Real patients describe getting denied again and again with a diabetes diagnosis — sometimes told the doctor’s office never sent the notes. Months lost to a paperwork gap, not a real “no.” Our answer to that friction is this page: the exact criteria, the documents, the denial fixes, and the honest fork in the road.


Frequently asked questions about UnitedHealthcare Mounjaro prior authorization

Does UnitedHealthcare require prior authorization for Mounjaro?
Yes. Mounjaro is on UnitedHealthcare's commercial drug list with prior authorization and a quantity limit, so your prescriber must get approval before the plan pays. Your specific plan's benefit still controls final coverage.
What A1C do you need for UHC to approve Mounjaro?
An A1C of 6.5% or higher meets UHC's diabetes-diagnosis requirement. You can also qualify with a fasting glucose of 126 mg/dL or more, a 2-hour glucose tolerance test of 200 mg/dL or more, a random glucose of 200 mg/dL or more with symptoms, or chart notes if you were diagnosed more than two years ago.
Does UnitedHealthcare make you try metformin first?
Not on the standard commercial policy. UnitedHealthcare removed step-therapy language from its commercial GLP-1 policy in April 2024, so failing metformin first isn't part of the base criteria. Some employer plans may add their own step therapy, so confirm your plan.
Does UnitedHealthcare cover Mounjaro for weight loss?
Generally no. UHC treats Mounjaro as a type 2 diabetes drug, says these GLP-1s aren't FDA-approved for weight loss, and typically excludes weight-loss use unless your plan adds the benefit. For weight loss, the better-matched FDA-approved option is Zepbound, with its own coverage path.
How long does UnitedHealthcare Mounjaro prior authorization take?
It varies by plan and request type. Many plans decide a standard pharmacy PA within a few business days to about two weeks, and urgent requests faster. Ask UnitedHealthcare or OptumRx for the deadline tied to your request, the authorization number, and whether expedited review is available if a delay could affect your care.
How long is a UHC Mounjaro authorization good for?
Twelve months. After that, your prescriber submits a renewal, ideally with current notes and your diagnosis history.
My A1C is normal now because Mounjaro is working. Will UHC still cover it?
It can. Ask your clinician to include your original diagnosis labs and treatment history. UHC's policy has a path for people diagnosed more than two years ago that relies on documented history rather than a fresh high A1C.
Can I use the Mounjaro Savings Card if UHC denies coverage?
Possibly, if you meet Lilly's terms. With commercial insurance that doesn't cover Mounjaro, eligible patients may pay as low as $499 for a one-month fill, but the prescription must be for an FDA-approved use, government plans are excluded, and the card expires 12/31/2026.
Is Zepbound easier to get covered than Mounjaro?
Not automatically. Zepbound is the better policy match when the reason is weight loss, but only if your plan turned on weight-loss drug coverage or you qualify for an exception. Many self-funded employer plans exclude weight-loss drugs.
Who files the appeal -- me or my doctor?
Either can. UnitedHealthcare allows an appeal from the member, a representative, or the provider. In practice, your prescriber usually needs to supply the clinical evidence that answers the denial.

Still not sure which GLP-1 program is right for you?

Take our free 60-second matching quiz. We’ll help you sort insurance, brand-name medication, and cash-pay options, and point you to a clear next step — without making you guess the right path first.

Get my personalized GLP-1 action plan →Weight-loss goal? Check Zepbound coverage on Ro → (sponsored affiliate link, opens in a new tab)
By The RX Index Editorial Team. This article is for general information and is not medical advice or a guarantee of insurance coverage. Medication decisions are made by licensed clinicians; coverage decisions are made by your health plan. Always read the FDA Medication Guide and talk with your prescriber. Last verified: .

Sources we verified

  1. UnitedHealthcare -- 2026 Commercial Prescription Drug List, effective May 1, 2026
  2. UnitedHealthcare -- Commercial Prior Authorization/Notification: Diabetes Medications -- GLP-1 & Dual GIP/GLP-1 Receptor Agonists (effective July 1, 2025)
  3. UnitedHealthcare -- Pre- and post-service appeals and reconsiderations
  4. Centers for Medicare & Medicaid Services -- Medicare GLP-1 Bridge
  5. Eli Lilly -- Mounjaro Savings Card terms (Resources for Saving)
  6. Eli Lilly -- Mounjaro cost & list price information
  7. FDA prescribing information (DailyMed) -- Mounjaro (tirzepatide), revised April 2026
  8. Ro -- GLP-1 Insurance Coverage Checker and Mounjaro availability